id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0436-0001,FDA,FDA-2011-D-0436,Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability: International Conference on Harmonisation,Notice,Notice of Availability,2011-06-29T04:00:00Z,2011,6,2011-06-29T04:00:00Z,2011-09-02T03:59:59Z,2011-06-29T16:56:50Z,2011-16255,0,0,0900006480eb650e
FDA-2011-D-0436-0002,FDA,FDA-2011-D-0436,Q11 Development and Manufacture of Drug Substances; International Conference on Harmonisation - Draft Guidance,Other,Guidance,2011-06-29T04:00:00Z,2011,6,2011-06-29T04:00:00Z,,2019-08-21T18:36:13Z,,0,0,0900006480eb66f1